Office of New Animal Drug Evaluation, Center for Veterinary Medicine, US Food and Drug Administration (FDA), Rockville, Maryland, USA.
Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, Maryland, USA.
AAPS J. 2022 May 2;24(3):61. doi: 10.1208/s12248-022-00713-1.
It is now recognized that a number of excipients previously considered to be "inert" have the capacity to alter drug oral bioavailability through a range of in vivo effects. The various mechanisms through which an excipient can affect in vivo gastrointestinal physiology and drug absorption characteristics were explored in "A Critical Overview of The Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption." The next critical issue that needs to be discussed is how these biological effects are evaluated. Therefore, in Part 2 of this critical overview, the in vitro, in vivo, and in silico methods for evaluating excipient effects are considered. Examples are provided to illustrate how such studies employing these various procedures have been used to promote formulation understanding and optimization. Finally, a discussion of how the Center for Drug Evaluation and Research applies these tools to support biowaivers is provided.
现在人们已经认识到,以前被认为是“惰性”的一些辅料通过一系列体内作用具有改变药物口服生物利用度的能力。在“辅料的生物学效应的批判性概述(第一部分):对胃肠道吸收的影响”中,探讨了辅料可以影响体内胃肠道生理学和药物吸收特性的各种机制。下一个需要讨论的关键问题是如何评估这些生物学效应。因此,在本批判性概述的第二部分中,考虑了评估辅料效应的体外、体内和计算方法。提供了示例来说明如何使用这些各种程序的研究来促进制剂的理解和优化。最后,讨论了药品评价和研究中心如何应用这些工具来支持生物豁免。